EVERSANA’s Post

Did you miss our Nov. 29th webinar in partnership with the Regulatory Affairs Professionals Society (RAPS)? No worries! Watch the recording now to delve into insightful discussions with Roche, Pfizer, Alexion Pharmaceuticals, Inc., and Certara experts on leveraging today's technology for accelerated submission success. https://ow.ly/UBfi50Qg4NY #RegulatorySubmissions #RegulatoryAffairs #RegulatoryScience #MedicalWriting

Medical conferences are increasingly hybrid, to make the most of both virtual and face-to-face participation. How can companies and those attending maximise their impact in this hybrid environment? If you are working in Medical Affairs at a pharmaceutical company, please share your insights for a question and answer thought leadership piece for FirstWord. Get in touch! leels@btinternet.com. #medicalaffairs #medicalconference

Completed an enlightening course on Digital Marketing of Medical Devices at Medico Industrien that provided invaluable insights and expertise in navigating the marketing law within the medical device and pharmaceutical sectors' complex terrain.   Great to expand my knowledge and skill set in this critical area together with Siska Jørgensen. As we continue to witness innovations in healthcare technology, I'm excited to apply what we've learned to drive impact in the field.   #DigitalMarketing #MedicalDevices #MarketingLaw #Healthcare #Medico

Less than two weeks until what promises to be another dynamic Medical Affairs Professional Society (MAPS) Conference. Thrilled to be joining Monica de Abadal and Arron Mungul for our workshop, "Learnings from 1000 launches: How Medical Affairs can drive launch success". This workshop will examine the latest challenges faced in launch preparation and facilitate discussion on how Medical Affairs can play a lead role in overcoming these challenges to achieve product success and best outcomes for patients. If you're attending #MAPS2024 we hope you can join one of our two sessions! #medicalaffairs #pharmaceuticals #biotech #medicaldevices

💬 𝗖𝗿𝗶𝘁𝗶𝗰𝗮𝗹 𝗿𝗲𝗽𝗼𝗿𝘁 𝘂𝗻𝗱𝗲𝗿 𝘁𝗵𝗲 𝗖𝗢𝗠𝗕𝗜𝗡𝗘 𝗶𝗻𝗶𝘁𝗶𝗮𝘁𝗶𝘃𝗲, shedding light on the complexities and barriers in conducting combined studies involving drugs, IVDs, and MDs. ◾ 𝗪𝗵𝘆 𝗧𝗵𝗶𝘀 𝗠𝗮𝘁𝘁𝗲𝗿𝘀? Combined studies are crucial for advancing innovative and personalized treatments for patients across Europe. Addressing these regulatory challenges is essential to facilitate smoother, more efficient clinical research processes. 🔗 Read the full article published by Regulatory Affairs Professionals Society (RAPS) for an in-depth understanding of these barriers and potential solutions: https://lnkd.in/egE3CD_A #ClinicalTrials #MedicalDevices #IVD #RegulatoryChallenges #HealthcareInnovation #EURegulations #COMBINEInitiative #MedTech #HealthcareCompliance #MDSS #ECREP #NEWS #MDR #IVDR

If you are willing to learn more about Venn’s ATMP capabilities then download our latest #factsheet.

Following the results of our recent poll asking for the most important factor when selecting your clinical trial supply partner, CSI understands that end-to-end clinical trial supply solutions are a priority. Discover how CSI’s comprehensive oversight and coordination ensure the right medicines are available at the right place, time and condition, all while maintaining compliance and cost-effectiveness. Read more to learn how CSI keeps clinical trials running smoothly and efficiently on behalf of our biotech and pharma partners: https://lnkd.in/eSWsrRf3 #ClinicalTrials #FullSupplyChainManagement #ComparatorSourcing  

The new EU regulation on health technology assessment will be introduced as soon as 2025 and slowly spread across all medicinal products. What does this mean for your development and market access plan? Come find out on our online training ‘Joint Clinical Assessments and Reform of the EU Pharma Law’ and get actionable strategic recommendations for your program. #pharma #EUpharma #HTAR #drugdevelopment #onlinetraining

In today’s rapidly evolving healthcare landscape, Medical Affairs plays a crucial role in communicating complexity across the treatment pathway. Danie du Plessis, EVP Pharmaceutical Operations at KKI, recently shared his perspectives on this with The Pharma Letter, including: 📢 The vital role of Medical Affairs in sharing complex information across audiences and channels 🔬 How Medical Affairs is keeping pace with scientific innovation to unlock greatest patient benefits 📈 How the function is growing rapidly to meet the changing needs of stakeholders Read the full article below! #KKIMakingPeopleSmile #MedicalAffairs

[7 days to go] Have you registered for 31st yet? Join Scott Sawler and Nutan B for an insightful session on GenAI in pharmaceuticals R&D, emphasizing regulatory affairs and medical writing. Link to Register: https://bit.ly/48jzg4A Scott Sawler is the former DG of Marketed Health Products Directorate, Health Canada and Nutan B is Gramener’s VP – Consulting. The webinar will focus on patient privacy and regulatory efficiency in drug development life cycle with Gen AI. #webinar #pharmaceuticalindustry #generativeai #largelanguagemodels #gramener